Combined hepatocellular cholangiocarcinoma: A clinicopathological update

doi:10.4254/wjh.v16.i5.766

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2006)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

HTML

1463

Figures (1-2)

156

Tables (1-3)

152

Sum=1822

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=101

May 27, 2024 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. May 27, 2024; 16(5): 766-775
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.766

Full Size Figure Download Figure

Figure 2 Demonstrates immunohistochemical features of combined hepatocellular-cholangiocarcinoma. A: Hep-par1 immunostaining in hepatocellular component (× 5); B: Strong EMA immunostaining in cholangiocarcinoma component (× 3); C: Nestin immunostaining in a combined hepatocellular- cholangiocarcinoma (× 7.5).

Citation: Vij M, Veerankutty FH, Rammohan A, Rela M. Combined hepatocellular cholangiocarcinoma: A clinicopathological update. World J Hepatol 2024; 16(5): 766-775
URL: https://www.wjgnet.com/1948-5182/full/v16/i5/766.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i5.766